Dow Up 0.48% Nasdaq Up 0.43%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
13.40 Aug 19, 4:00PM EDT
Prev Close:13.40
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:17.73
Beta:3.23
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:N/A - N/A
52wk Range:4.55 - 14.62
Volume:0
Avg Vol (3m):1,462,800
Market Cap:961.53M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRX 0.00%961.53M
GSK113.73B
RHHBY248.97B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):53.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-2.24

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback